|
Steve Moreci is Senior Vice President and Group President for Endosurgery responsible for Boston Scientific's Endoscopy Urology/Gynecology and Oncology businesses.
Steve joined Boston Scientific in 1989 as Vice President and General Manager for the Cardiac Assist business. In 1991 he was appointed Vice President and General Manager for the newly formed Endoscopy business. In 1994 Steve was given the additional responsibility for the company‘s Urology and Gynecology business and was promoted to Group Vice President.
By 1997 the Endoscopy business had grown from $19 million to over $300 million recording six years of double-digit global growth. In recognition of his accomplishments and to enable Steve to focus full time on the growing Endoscopy business Steve was promoted to President Endoscopy. In 1999 Steve was named President of the Boston Scientific‘s Vascular business which included Peripheral Interventions Vascular Surgery and Oncology. In 2000 and 2001 he helped successfully transfer the Peripheral Interventions and the Vascular Surgery businesses to the Cardiovascular Group. In 2000 Steve recommended the establishment of a new business group Endosurgery to provide focus on the significant growth opportunities in emerging Quality of Life technologies and in Women‘s Health. In late 2000 Steve was promoted to the Boston Scientific Executive Committee and was named Senior Vice President and Group President for Endosurgery.
Prior to his joining Boston Scientific Steve enjoyed a 13-year career in Medical Devices including 9 years with Johnson and Johnson where he held a variety of sales and marketing positions. From 1985 to his joining Boston Scientific Steve was Vice President of Sales and Marketing for DermaCare a small medical device firm that supplied finished goods and components to a variety of multi-national medical device firms including Zimmer and Baxter.
He holds a B.S. in Marketing from Pennsylvania State University. | 